Compounds > alpha-methyl-m-tyrosine
Page last updated: 2024-10-22

alpha-methyl-m-tyrosine and Acute Disease

alpha-methyl-m-tyrosine has been researched along with Acute Disease in 2 studies

alpha-methyl-m-tyrosine: RN given refers to cpd without stereoisomeric designation; structure in Merck Index, 9th ed, #6004

Acute Disease: Disease having a short and relatively severe course.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iyengar, S1
Webster, AA1
Hemrick-Luecke, SK1
Xu, JY1
Simmons, RM1
Carlsson, L1

Other Studies

2 other studies available for alpha-methyl-m-tyrosine and Acute Disease

ArticleYear
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:2

    Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cycl

2004
Mechanisms of local noradrenaline release in acute myocardial ischemia.
    Acta physiologica Scandinavica. Supplementum, 1987, Volume: 559

    Topics: Acute Disease; Animals; Coronary Circulation; Coronary Disease; Heart; Male; Methyltyrosines; Norepi

1987